Health product recall

Mylan-Lamotrigine(2021-03-29)

Starting date:
March 29, 2021
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-75341

Last updated: 2021-04-08

Summary

  • Product: Mylan-Lamotrigine(2021-03-29)

Reason

The dissolution is out of specification in the affected lot.

Depth of distribution

Wholesalers

Affected products

Mylan-Lamotrigine

DIN, NPN, DIN-HIM

DIN 02265494

Dosage form

Tablet

Strength

Lamotrigine 25 mg

Lot or serial number

  • 3113009

Companies

Recalling Firm
Mylan Pharmaceuticals ULC
85 Advance Road
Etobicoke
M8Z 2S6
Ontario
CANADA
Marketing Authorization Holder
Mylan Pharmaceuticals ULC
85 Advance Road
Etobicoke
M8Z 2S6
Ontario
CANADA